| Authors: |
Mitchell E; Wellcome Sanger Institute, Hinxton, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Pham MH; Wellcome Sanger Institute, Hinxton, UK., Clay A; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK., Sanghvi R; Wellcome Sanger Institute, Hinxton, UK., Williams N; Wellcome Sanger Institute, Hinxton, UK., Pietsch S; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Hsu JI; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Øbro NF; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Jung H; Wellcome Sanger Institute, Hinxton, UK., Vedi A; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Paediatrics, Cambridge University Hospitals Foundation Trust, Cambridge, UK., Moody S; Wellcome Sanger Institute, Hinxton, UK., Wang J; Wellcome Sanger Institute, Hinxton, UK., Leonganmornlert D; Wellcome Sanger Institute, Hinxton, UK., Spencer Chapman M; Wellcome Sanger Institute, Hinxton, UK., Dunstone E; Wellcome Sanger Institute, Hinxton, UK., Santarsieri A; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Cagan A; Wellcome Sanger Institute, Hinxton, UK., Machado HE; Wellcome Sanger Institute, Hinxton, UK., Baxter EJ; Department of Haematology, University of Cambridge, Cambridge, UK., Follows G; Department of Haematology, University of Cambridge, Cambridge, UK., Hodson DJ; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., McDermott U; Wellcome Sanger Institute, Hinxton, UK.; Department of Oncology, Cambridge University Hospitals Foundation Trust, Cambridge, UK.; Oncology R&D, AstraZeneca, Cambridge, UK., Doherty GJ; Department of Oncology, Cambridge University Hospitals Foundation Trust, Cambridge, UK., Martincorena I; Wellcome Sanger Institute, Hinxton, UK., Humphreys L; Wellcome Sanger Institute, Hinxton, UK., Mahbubani K; Department of Surgery, University of Cambridge, Cambridge, UK.; Cambridge Biorepository for Translational Medicine, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Saeb Parsy K; Department of Surgery, University of Cambridge, Cambridge, UK.; Cambridge Biorepository for Translational Medicine, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Takahashi K; Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Goodell MA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Kent D; York Biomedical Research Institute, Department of Biology, University of York, York, UK., Laurenti E; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Campbell PJ; Wellcome Sanger Institute, Hinxton, UK., Rahbari R; Wellcome Sanger Institute, Hinxton, UK., Nangalia J; Wellcome Sanger Institute, Hinxton, UK. jn5@sanger.ac.uk.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK. jn5@sanger.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk., Stratton MR; Wellcome Sanger Institute, Hinxton, UK. mrs@sanger.ac.uk. |
